These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16604299)

  • 21. The neuromelanin of the human substantia nigra.
    Carstam R; Brinck C; Hindemith-Augustsson A; Rorsman H; Rosengren E
    Biochim Biophys Acta; 1991 Sep; 1097(2):152-60. PubMed ID: 1911888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dolichol is the major lipid component of human substantia nigra neuromelanin.
    Fedorow H; Pickford R; Hook JM; Double KL; Halliday GM; Gerlach M; Riederer P; Garner B
    J Neurochem; 2005 Feb; 92(4):990-5. PubMed ID: 15686500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural characteristics of human substantia nigra neuromelanin and synthetic dopamine melanins.
    Double KL; Zecca L; Costi P; Mauer M; Griesinger C; Ito S; Ben-Shachar D; Bringmann G; Fariello RG; Riederer P; Gerlach M
    J Neurochem; 2000 Dec; 75(6):2583-9. PubMed ID: 11080212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipid content determines aggregation of neuromelanin granules in vitro.
    Dedov VN; Griffiths FM; Garner B; Halliday GM; Double KL
    J Neural Transm Suppl; 2007; (72):35-8. PubMed ID: 17982875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.
    Hansen AK; Knudsen K; Lillethorup TP; Landau AM; Parbo P; Fedorova T; Audrain H; Bender D; Østergaard K; Brooks DJ; Borghammer P
    Brain; 2016 Jul; 139(Pt 7):2039-49. PubMed ID: 27190023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes.
    Zecca L; Gallorini M; Schünemann V; Trautwein AX; Gerlach M; Riederer P; Vezzoni P; Tampellini D
    J Neurochem; 2001 Mar; 76(6):1766-73. PubMed ID: 11259494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The aging substantia nigra: quantitative histologic study.
    Faraldi F; Reyes MG; Alfieri E; Levi AC
    Panminerva Med; 1994 Sep; 36(3):103-8. PubMed ID: 7877822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of neuromelanin and iron in substantia nigra and other areas of human brain.
    Zecca L; Shima T; Stroppolo A; Goj C; Battiston GA; Gerbasi R; Sarna T; Swartz HM
    Neuroscience; 1996 Jul; 73(2):407-15. PubMed ID: 8783258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ferritin and neuromelanin "quantum dot" array structures in dopamine neurons of the substantia nigra pars compacta and norepinephrine neurons of the locus coeruleus.
    Rourk CJ
    Biosystems; 2018 Sep; 171():48-58. PubMed ID: 30048795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuromelanin accumulation with age in catecholaminergic neurons from Macaca fascicularis brainstem.
    Herrero MT; Hirsch EC; Kastner A; Luquin MR; Javoy-Agid F; Gonzalo LM; Obeso JA; Agid Y
    Dev Neurosci; 1993; 15(1):37-48. PubMed ID: 7505739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cysteinyldopamine is not incorporated into neuromelanin.
    Wakamatsu K; Ito S; Nagatsu T
    Neurosci Lett; 1991 Sep; 131(1):57-60. PubMed ID: 1791980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The comparative biology of neuromelanin and lipofuscin in the human brain.
    Double KL; Dedov VN; Fedorow H; Kettle E; Halliday GM; Garner B; Brunk UT
    Cell Mol Life Sci; 2008 Jun; 65(11):1669-82. PubMed ID: 18278576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. (-)deprenyl and (-)parafluorodeprenyl-treatment prevents age-related pigment changes in the substantia nigra. A TV-image analysis of neuromelanin.
    Knoll J; Tóth V; Kummert M; Sugár J
    Mech Ageing Dev; 1992 Apr; 63(2):157-63. PubMed ID: 1602844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The enigma of neuromelanin in Parkinson's disease substantia nigra.
    Youdim MB; Ben-Shachar D; Riederer P
    J Neural Transm Suppl; 1994; 43():113-22. PubMed ID: 7884393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuromelanic pigment in substantia nigra neurons of rats and dogs.
    DeMattei M; Levi AC; Fariello RG
    Neurosci Lett; 1986 Dec; 72(1):37-42. PubMed ID: 3492690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intracellular chemical imaging of the developmental phases of human neuromelanin using synchrotron X-ray microspectroscopy.
    Bohic S; Murphy K; Paulus W; Cloetens P; Salomé M; Susini J; Double K
    Anal Chem; 2008 Dec; 80(24):9557-66. PubMed ID: 19007186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation and 13C-NMR characterization of an insoluble proteinaceous fraction from substantia nigra of patients with Parkinson's disease.
    Aime S; Bergamasco B; Casu M; Digilio G; Fasano M; Giraudo S; Lopiano L
    Mov Disord; 2000 Sep; 15(5):977-81. PubMed ID: 11009208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Total and paramagnetic metals in human substantia nigra and its neuromelanin.
    Zecca L; Swartz HM
    J Neural Transm Park Dis Dement Sect; 1993; 5(3):203-13. PubMed ID: 8396395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracellular crowding by age-dependent neuromelanin accumulation disrupts neuronal proteostasis and triggers Parkinson disease pathology.
    Vila M; Laguna A; Carballo-Carbajal I
    Autophagy; 2019 Nov; 15(11):2028-2030. PubMed ID: 31480882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of autofluorescence emission spectra of bleached neuromelanin in non-diseased substantia nigra with spectra of other intraneuronal pigments in non-diseased and diseased tissue.
    Dowson JH
    Acta Neuropathol; 1983; 61(3-4):196-200. PubMed ID: 6650132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.